Ascelia Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 1999-01-01
- Employees
- 13
- Market Cap
- -
- Website
- http://www.cmc-contrast.se
Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function
Phase 3
Completed
- Conditions
- Severe Renal ImpairmentKnown or Suspected Focal Liver Lesions
- Interventions
- First Posted Date
- 2019-10-08
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Ascelia Pharma AB
- Target Recruit Count
- 87
- Registration Number
- NCT04119843
- Locations
- 🇺🇸
Saint Louis University, Saint Louis, Missouri, United States
🇺🇸University of Wisconsin - Madison, Madison, Wisconsin, United States
🇮🇹Università Cattolica del Sacro Cuore, Roma, Italy
© Copyright 2025. All Rights Reserved by MedPath